Breaking News Instant updates and real-time market news.

PDCO

Patterson Companies

$47.51

1.02 (2.19%)

, XRAY

Dentsply Sirona

$59.88

-0.28 (-0.47%)

09:22
11/22/16
11/22
09:22
11/22/16
09:22

On The Fly: Pre-market Movers

UP AFTER EARNINGS: Dollar Tree (DLTR), up 8.5%... Signet Jewelers (SIG), up 9%... Movado (MOV), up 10.7%... Burlington Stores (BURL), up 10.5%... Cracker Barrel (CBRL), up 6%... Analog Devices (ADI), up 4%... DSW (DSW), up 1.4%. ALSO HIGHER: Anavex (AVXL), up 21.6% after reporting that Alzheimer's patients taking a daily oral dose of ANAVEX 2-73 in the exploratory, not yet dose optimized, Phase 2a clinical trial showed a stabilization of cognitive and functional measures... Hormel Foods (HRL), up 4.5% after reporting earnings, boosting its dividend and announcing a deal to sell Clougherty Packing, the parent company of Farmer John and Saag's Specialty Meats, along with PFFJ farm operations in California, Arizona, and Wyoming to Smithfield Foods. DOWN AFTER EARNINGS: Medtronic (MDT), down 7.5%... Palo Alto Networks (PANW), down 11%. ALSO LOWER: Patterson Companies (PDCO), down 17% after reporting earnings, cutting its FY17 adjusted EPS view and reporting that it will not extend the exclusive portion of its Dentsply Sirona (XRAY) relationship beyond September 2017... FireEye (FEYE), down 4.5% after the stock was downgraded to Sell from Neutral at Goldman... Tenet (THC), down 3.5% after being downgraded to Underperform from Neutral at Mizuho.

PDCO

Patterson Companies

$47.51

1.02 (2.19%)

XRAY

Dentsply Sirona

$59.88

-0.28 (-0.47%)

AVXL

Anavex

$3.29

0.01 (0.30%)

PANW

Palo Alto Networks

FEYE

FireEye

$13.87

0.24 (1.76%)

MDT

Medtronic

SIG

Signet Jewelers

DLTR

Dollar Tree

$81.99

0.08 (0.10%)

HRL

Hormel Foods

BURL

Burlington Stores

ADI

Analog Devices

$69.82

1.35 (1.97%)

DSW

DSW

THC

Tenet

MOV

Movado

  • 22

    Nov

  • 22

    Nov

  • 22

    Nov

  • 22

    Nov

  • 22

    Nov

  • 22

    Nov

  • 22

    Nov

  • 22

    Nov

  • 22

    Nov

  • 28

    Nov

  • 28

    Nov

  • 29

    Nov

  • 05

    Dec

  • 08

    Dec

  • 08

    Dec

PDCO Patterson Companies
$47.51

1.02 (2.19%)

10/05/16
UBSW
10/05/16
INITIATION
Target $48
UBSW
Neutral
Patterson Companies initiated with a Neutral at UBS
Target $48.
11/21/16
BARD
11/21/16
NO CHANGE
BARD
Outperform
Baird expects Amazon.com distribution announcement with Patterson
Following industry conversions, Baird analyst Jeff Johnson expects Patterson Companies (PDCO) to announce an Amazon.com (AMZN) distribution agreement tomorrow. What the analyst hadnt considered and is now hearing is that Amazon could fulfill orders placed through Patterson's order portal, lowering Patterson's fulfillment costs and given the company breathing room as it pursues DSO deals. Johnson rates Patterson a Neutral with a $48 price target.
11/01/16
NRCS
11/01/16
NO CHANGE
NRCS
Amazon.com should partner with Patterson Companies, says Northcoast
Northcoast said Amazon.com (AMZN) has a strong interest in entering the dental market and has spent time and resources attempting to build relationships with manufacturers and distributors to gain product procurement, which so far has been unsuccessful. The firm's analyst said Patterson (PDCO) is aggressively trying to reinvent how dental distribution will occur in the future and is building a new IT backbone, making huge investments in technical service. Northcoast said Patterson is on a path to disrupt the industry and could accelerate this effort with a partnership with Amazon. The firm continues to view Patterson as undervalued, with out without Amazon, and recommends investors build positions at this time.
08/26/16
PIPR
08/26/16
NO CHANGE
PIPR
Dentsply Sirona should be bought on weakness, says Piper Jaffray
After Patterson Companies (PDCO) reported that dental consumables growth had decelerated to 0.9% last quarter, Piper Jaffray analyst Matt O'Brien notes that the company said that the category rebounded in August, while it anticipated further improvements in the business over the next 6-12 months. O'Brien adds that Dentsply Sirona (XRAY) should be helped by "solid domestic" macro trends, and he recommends that investors buy Dentsply Sirona on weakness.
XRAY Dentsply Sirona
$59.88

-0.28 (-0.47%)

09/22/16
09/22/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: Packaging Corp. (PKG) initiated with a Sell at Goldman. 2. Netlist (NLST) initiated with a Buy at B. Riley. 3. Weyerhaeuser (WY) initiated with a Conviction Buy at Goldman. 4. bluebird bio (BLUE) reinstated with a Buy at Roth Capital. 5. Dentsply Sirona (XRAY) initiated with a Neutral at JPMorgan. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
09/22/16
JPMS
09/22/16
INITIATION
Target $65
JPMS
Neutral
Dentsply Sirona initiated with a Neutral at JPMorgan
JPMorgan analyst Tycho Peterson started Dentsply Sirona with a Neutral rating and $65 price target. The analyst cites the stock's "premium valuation" for his rating and recommends for a pullback in the shares.
11/01/16
MSCO
11/01/16
UPGRADE
MSCO
Overweight
Dentsply Sirona upgraded to Overweight from Equal Weight at Morgan Stanley
11/01/16
11/01/16
UPGRADE
Target $69

Overweight
Dentsply Sirona upgraded on growth, valuation at Morgan Stanley
As previously reported, Morgan Stanley upgraded Denstply Sirona to Overweight from Equal Weight and raised its price target to $69 from $65. Analyst Steve Beuchaw said Densply's relative valuation weakness positions the company for better performance despite negative dental market sentiment. He expects Dentsply's organic growth to accelerate in 2017 driven by digital dentistry adoption, a focus on commercial headcount, easing digital equipment comps, and revenue synergies. Beauchaw expects the company's double digit free cash flow growth potential to improve investor sentiment.
AVXL Anavex
$3.29

0.01 (0.30%)

11/30/15
MAXM
11/30/15
NO CHANGE
Target $15
MAXM
Buy
Anavex publishes positive data for ANAVEX 3-71, says Maxim
Maxim analyst Jason Kolbert said Anavex announced additional positive data for ANAVEX 3-71 in the respected journal, Neurodegenerative Diseases. Kolbert said the data provided more upstream effect on reducing syanptic loss, amyloid and tau pathologies, and neuroinflammation, which is potentially beneficial for the treatment of Alzheimer's and other neurological diseases. The analyst rates Anavex a Buy with a $15 price target on shares.
03/29/16
FBRC
03/29/16
INITIATION
Target $10
FBRC
Outperform
Anavex initiated with an Outperform at FBR Capital
FBR Capital analyst Christopher James started Anavex Life Sciences with an Outperform rating and $10 price target.
12/30/15
MAXM
12/30/15
NO CHANGE
Target $15
MAXM
Buy
Anavex subpoena not related to wrongdoing by company, says Maxim
Maxim analyst Jason Kolbert said he does not believe the SEC subpoena disclosed yesterday by Anavex involves any wrongdoing by the company or its management. The analyst, who notes that ANAVEX 2-73 continues to show signs of early efficacy in Alzheimer's disease, keeps Buy rating and $15 price target on the stock.
PANW Palo Alto Networks

11/22/16
MAXM
11/22/16
NO CHANGE
Target $185
MAXM
Buy
Palo Alto Networks technology still 'best-in-class,' says Maxim
Maxim analyst Nehal Chokshi blames Palo Alto Networks' Q1 revenue miss and softer Q2 guidance to an extension in its large deal sales cycle. However, despite seeing limited upside for the remainder of FY17, he continues to believe that Palo Alto has a best-in-class network security capability and keeps a Buy rating and $185 price target on the shares.
11/22/16
PIPR
11/22/16
NO CHANGE
Target $178
PIPR
Overweight
Palo Alto Networks still posting 31% revenue growth, says Piper Jaffray
Piper Jaffray analyst Andrew Nowinski points out that despite the "disappointing" Q1 results, Palo Alto Networks (PANW) is still generating 31% revenue growth, which is three-times above closest competitor Cisco (CSCO). He recommends investors hold the stock through the selling pressure. Nowinski lowered his price target for Palo Alto shares to $178 from $184 and keeps an Overweight rating on the name.
11/22/16
PACS
11/22/16
NO CHANGE
PACS
Palo Alto Networks long-term opportunity still positive, says Pacific Crest
After Palo Alto reported weaker than expected results, Pacific Crest analyst Rob Owens blames the miss on "extended deal cycles requiring additional approval." .However, the analyst continues to believe that its growth is "impressive," and he thinks that it still has one of the best longer term outlooks of any IT security company.He keeps a $190 price target and an Overweight rating on the shares.
11/22/16
JPMS
11/22/16
NO CHANGE
Target $170
JPMS
Overweight
Palo Alto Networks price target lowered to $170 from $196 at JPMorgan
JPMorgan analyst Sterling Auty lowered his price target for Palo Alto Networks to $170 after the company reported its second-ever revenue miss. Deal slippage on elongated sales cycles in the enterprise led to a shortfall in billings/revenue, Auty tells investors in a post-earnings research note. The miss makes the year more back-end loaded and will likely have investors questioning the company's ability to hit the 12%-13% product revenue growth guidance that was maintained for FY17, the analyst contends. Auty lowered his estimate for product growth down to 11% and keeps an Overweight rating on Palo Alto shares.
FEYE FireEye
$13.87

0.24 (1.76%)

11/22/16
GSCO
11/22/16
DOWNGRADE
Target $11
GSCO
Sell
FireEye downgraded to Sell from Neutral at Goldman
Goldman analyst Gabriela Borges downgraded FireEye to Sell and lowered its price target to $11 from $15. The analyst said the Street is underestimating medium near-term risk from several product and business model transitions. He expects margins to remain pressured in 2017 due to changes in customer buying patterns and believes FireEye's move into the mid-market will be difficult to execute.
11/04/16
OPCO
11/04/16
NO CHANGE
Target $28
OPCO
Outperform
FireEye price target lowered to $28 from $33 at Oppenheimer
Oppenheimer analyst Shaul Eyal lowered his price target for FireEye to $28 from $33 on valuation. Following the company's "solid" Q3 results, the analyst is encouraged by the ongoing operational improvement as well as overall demand and product trends. Further, Eyal says it appears that FireEye's management team "has turned a corner steering it in the right direction." The analyst reiterates an Outperform rating on the shares.
10/24/16
10/24/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. AT&T (T)downgraded to Hold from Buy at Drexel Hamilton, and to Market Perform from Outperform at Cowen. 2. Time Warner (TWX) downgraded to Neutral from Outperform at Credit Suisse, to Neutral from Buy at MKM Partners, to Neutral from Conviction Buy at Goldman, to Neutral from Outperform at Macquarie, to Hold from Buy at Pivotal Research, to Neutral from Overweight at Atlantic Equities, to Neutral from Buy at MoffettNathanson, and to Sector Perform from Outperform at RBC Capital. 3. Everyday Health (EVDY) downgraded to Neutral from Outperform at Credit Suisse, to Hold from Buy at SunTrust, and to Market Perform from Outperform at Leerink. 4. Reynolds American (RAI) downgraded to Underperform from Outperform at CLSA with analyst Michael Lavery saying British American Tobacco's (BTI) $56.50 offer for Reynolds is a moving target and is now worth $55.50. 5. FireEye (FEYE) downgraded to Underweight from Equal-Weight at First Analysis with analyst Howard Smith saying the security spending environment favors other players in the space. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/21/16
FANA
10/21/16
DOWNGRADE
Target $11
FANA
Underweight
FireEye downgraded to Underweight from Equal-Weight at First Analysis
First Analysis analyst Howard Smith downgraded FireEye to Underweight saying the security spending environment favors other players in the space. The company's high cash burn will drive share underperformance, Smith tells investors in a research note. He cut his price target for the stock to $11 from $15. FireEye closed the trading day up 36c to $12.64.
MDT Medtronic

11/14/16
EVER
11/14/16
NO CHANGE
EVER
Medtronic, Edwards Lifesciences defended at Evercore ISI
11/02/16
BMOC
11/02/16
NO CHANGE
BMOC
Dexcom still has positive catalysts, says BMO Capital
After Dexcom reported higher than expected Q3 revenue but said it does not expect its 2016 revenue to come in above its previous guidance range, BMO Capital analyst Joanne Wuensch says that the company's Q4 and 2017 results will probably be negatively impacted by Medtronic's (MDT) upcoming MiniMed 670G product. Nonetheless, the analyst says that the pending non-adjunctive label for Dexcom's CGM "can make waves," while it has "ample" room for growth in its "vastly underserved" market, as its "technology is nowhere near its full potential." The analyst cut her price target on the shares to $90 from $112 but keeps an Outperform rating on the stock.
11/14/16
PIPR
11/14/16
NO CHANGE
PIPR
Overweight
Piper would buy TAVR names on 'GARY' registry weakness
Piper Jaffray analyst Brooks West attributes today's weakness in transcatheter aortic valve replacement makers Medtronic (MDT), Edwards Lifesciences (EW) and Boston Scientific (BSX) to a presentation at the AHA meeting of data from the German Aortic Valve Registry, or "GARY," comparing one year outcomes for patients at intermediate surgical risk who underwent isolated interventional versus conventional surgical aortic valve replacement for severe symptomatic aortic valve stenosis. The data showed a surprisingly negative result, but prior debates around the "GARY" led to no impact on TAVR volumes and West is "skeptical of the results," he tells investors. The firm has Overweight ratings on all three stocks mentioned above.
11/15/16
LEER
11/15/16
NO CHANGE
LEER
Edwards Lifesciences, Medtronic selloff overdone, says Leerink
Leerink analyst Danielle Antalffy notes that both Edwards Lifesciences (EW) and Medtronic (MDT) traded down in reaction to a presentation of the German Aortic Valve Registry data in intermediate risk patients. However, she believes the selloff is overdone, with no change to her estimated total addressable transcatheter aortic valve replacement, or TAVR, market opportunity as there are key baseline characteristic differences between both the surgical valve and TAVR groups that skews the data, and randomized controlled clinical trial data trumps registry data.
SIG Signet Jewelers

11/18/16
WELS
11/18/16
NO CHANGE
WELS
Signet Jewelers removed from Priority Stock List at Wells Fargo
Wells Fargo removed Signet from its Priority Stock List after conducting checks. The company's traffic appears to be characterized by "chopiness" and "elevated" promotions, while its Q4 compares are "tougher," according to the firm. However, it keeps an Outperform rating on the shares.
09/13/16
09/13/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Netflix (NFLX) downgraded to Underperform from Neutral at Macquarie with analyst Tim Nollen saying market penetration could be limited given new streaming video on demand competitors and local operator's streaming efforts. 2. Intuit (INTU) downgraded to Underweight from Equal Weight at Morgan Stanley with analyst Keith Weiss citing full valuation. 3. Applied Genetic (AGTC) downgraded to Market Perform from Outperform at Wells Fargo, to Sell from Buy at Janney Capital, to Hold from Buy at Cantor, and to Neutral from Buy at Roth Capital. 4. Signet Jewelers (SIG) downgraded to Market Perform from Outperform at Cowen with analyst Oliver Chen saying he believes shares will be range bound despite the stock's cheap valuation. 5. Red Robin (RRGB) downgraded to Underperform from Buy at BofA/Merrill with the firm citing the difficult casual dining environment, lack of near-term catalysts, and risk to third quarter earnings. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/28/16
LYON
09/28/16
INITIATION
LYON
Outperform
Signet Jewelers initiated with an Outperform at CLSA
CLSA analyst Rick Patel initiated Signet Jewelers with an Outperform rating and a $87 price target.
11/18/16
WELS
11/18/16
NO CHANGE
WELS
Outperform
Signet Jewelers removed from Priority Stock List at Wells Fargo
Wells Fargo analyst Ike Boruchow removed Signet Jewelers from his Priority Stock List saying his Q3 store work indicated "ongoing choppiness" in traffic trends and elevated levels of promotion. The analyst, however, still believes the company is well-positioned in the industry over the longer-term. He lowered his Q4 earnings estimate to $3.82 from $4.09 but keeps an Outperform rating on Signet with a $100-$105 price target range. Boruchow believes the stock's risk/reward remains favorable.
DLTR Dollar Tree
$81.99

0.08 (0.10%)

11/15/16
11/15/16
UPGRADE

Accumulate
Dollar Tree upgraded to Accumulate on Family Dollar progress at Johnson Rice
As previously reported, Johnson Rice upgraded Dollar Tree to Accumulate from Hold. Analyst David Mann has increased confidence in the long-term transformation at Family Dollar, the strong management team, lower investor expectations, and more attractive valuation.
11/15/16
JRCO
11/15/16
UPGRADE
JRCO
Accumulate
Dollar Tree upgraded to Accumulate from Hold at Johnson Rice
11/14/16
UBSW
11/14/16
NO CHANGE
Target $90
UBSW
Buy
Dollar Tree valuation is quite favorable, says UBS
UBS analyst Michael Lasser said Dollar Tree's valuation remains favorable. Lasser said top-line trends for Q3 were probably subdued but with the shares trading at a discount and its PE trading at just a sight premium to the S&P, soft trends will be reflective of a tough environment rather than a change in productivity. The analyst said margins should continue to gain as synergies with is Family Dollar acquisition accelerate. Lasser reiterated his Buy rating and $90 price target on Dollar Tree shares.
10/13/16
10/13/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Aaron's (AAN) initiated with a Buy at Jefferies. 2. eBay (EBAY) and Etsy (ETSY) coverage assumed with a Neutral at Wedbush. 3. Five Below (FIVE) and Dollar Tree (DLTR) were initiated with an Overweight at KeyBanc while the firm initiated Dollar General (DG) with a Sector Weight. 4. Baxter (BAX) initiated with an Outperform at Wells Fargo. 5. Symantec (SYMC) initiated with an Outperform at FBN Securities. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
HRL Hormel Foods

09/16/16
09/16/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Wal-Mart (WMT) coverage assumed with an Outperform from Neutral at Credit Suisse with analyst Edward Kelly saying he is encouraged by Wal-Mart's return to traffic growth against a deteriorating staples retail environment and its aggressive U.S. investments to solidify its position in an evolving industry. 2. Clorox (CLX) upgraded to Overweight from Neutral at Atlantic Equities. 3. Comerica (CMA) upgraded to Conviction Buy from Neutral at Goldman with analyst Ryan Nash saying he sees upside to Comerica's current recently announced strategic plan to improve pre-tax returns by $230M. 4. Hormel Foods (HRL) upgraded to Buy from Hold at Edward Jones. 5. Micron (MU) upgraded to Buy from Neutral at Cleveland Research with analyst Kevin Rottinghaus saying Micron's execution has improved and progress in DRAM and NAND fundamentals over the past 2-3 months is sustainable into 2017. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/16/16
EDJN
09/16/16
UPGRADE
EDJN
Buy
Hormel Foods upgraded to Buy from Hold at Edward Jones
09/15/16
OPCO
09/15/16
INITIATION
Target $38
OPCO
Perform
Hormel Foods initiated with a Perform at Oppenheimer
Oppenheimer analyst Rupesh Parikh initiated Hormel Foods with a Perform rating and $38 price target.
09/27/16
FBCO
09/27/16
NO CHANGE
Target $43
FBCO
Outperform
Hormel Foods added to US Focus List at Credit Suisse
Credit Suisse added Hormel Foods (HRL) to the US Focus List, replacing Kellogg (K). The firm Investment Policy Committee said analyst Rob Moskow's FY17 above consensus estimate reflects his view that the Street underestimates earnings momentum, is best positioned to capitalize on increased demand for convenient protein products and deflationary meat cost trends, higher margins from its mix to value-added products, and high short interest that will dissipate. Moskow rates Hormel an Outperform with a $43 price target.
BURL Burlington Stores

08/26/16
08/26/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Seaport Global upgraded PetroQuest (PQ) to Buy and raised its price target to $5 from $4, citing reduced near-term balance sheet concerns and a potential Cotton Valley joint-venture partner by year-end. 2. MKM Partners upgraded Burlington Stores (BURL) to Buy from Neutral and increased its price target to $94 from $73. The analyst said two quarters of comp beats demonstrate strong momentum and sees catalysts for continued comp growth, continued refinement of the offprice model, outsized growth in home and beauty, and gross margin expansion. 3. Credit Suisse upgraded Petrobras (PBR) to Neutral and raised its price target to $8.60 from $2. The analyst believes management can add value through cost and capex cuts, divestments, fuel pricing, and strategic changes. 4. HSBC upgraded Southern Copper (SCCO) to Buy and raised its price target to $31.50 from $27. The analyst believes copper prices have bottomed and expects better production growth, higher by-product commodity prices, increasing free cash flow, and an improving balance sheet. 5. Northcoast upgraded A. Schulman (SHLM) to Buy and established a $30 price target. The analyst said risk/reward is favorable and sees catalysts from the reintroduction of Joe Gingo as CEO and his business plan review. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/30/16
GUGG
09/30/16
INITIATION
GUGG
Neutral
Burlington Stores initiated with a Neutral at Guggenheim
09/26/16
BOFA
09/26/16
NO CHANGE
Target $95
BOFA
Buy
Burlington Stores price target raised to $95 from $90 at BofA/Merrill
BofA/Merrill analyst Lorraine Hutchinson believes Burlington will generate strong comps in 2H 2016 due to positive supply chain dislocations, the Hanjin bankruptcy causing competitor product delays, and store closings at Macy's. The analyst reiterates his Buy rating on Burlington and raised its price target to $95 from $90.
11/09/16
COWN
11/09/16
NO CHANGE
Target $90
COWN
Outperform
Burlington Stores short report has several unfair characterizations, says Cowen
Cowen analyst John Kiernan noted Burlington faced several negative headlines on third party credit card data, poor weather trends, and retail traffic. He also said a recent "short report" regarding Burlington had several unfair characterizations. Kiernan maintained his Outperform rating and $90 price target on Burlington Store shares.
ADI Analog Devices
$69.82

1.35 (1.97%)

10/20/16
10/20/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Expedia (EXPE) initiated with a Positive at Susquehanna. 2. Analog Devices (ADI) initiated with an Outperform at CLSA. 3. TripAdvisor (TRIP) initiated with a Neutral at Susquehanna. 4. Columbia Sportswear (COLM) initiated with a Neutral at Buckingham. 5. Scotts Miracle-Gro (SMG) initiated with a Buy at Gabelli. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
10/26/16
KEYB
10/26/16
NO CHANGE
KEYB
Apple results positive for iPhone suppliers, says KeyBanc
KeyBanc says that Apple's (AAPL) results were modestly positive for iPhone suppliers Analog Devices (ADI), Broadcom (AVGO), Cirrus Logic (CRUS), InvenSense ((INVN), ON Semiconductor (ON), Qorvo (QRVO), Skyworks (SWKS), Synaptics (SYNA), TSMC (TSM), and Texas Instruments (TXN). The firm expects the companies'' earnings to beat expectations slightly. It identifies Analog Devices, Broadcom, Skyworks, and Synaptics as its favorite names among Apple suppliers.
11/14/16
RBCM
11/14/16
NO CHANGE
RBCM
Analog Devices likely to report beat and raise results, says RBC Capital
RBC Capital analyst Amit Daryanani, expects Analog Devices to report beat and raise October quarter results, driven by multiple positive catalysts, including strong sales of Apple's iPhones, the stabilization of demand for passive safety systems in autos after multiple quarters of declines, and the high probability that the company's prior guidance was conservative. He keeps a $75 price target and an Outperform rating on the shares.
11/16/16
MSCO
11/16/16
NO CHANGE
Target $78
MSCO
Overweight
Morgan Stanley positive on Analog Devices ahead of earnings and into 2017
Morgan Stanley analyst Craig Hettenbach said Analog Devices (ADI) is one of his top Overweight picks and sees upside to earnings for the next 2 quarters given strength in broad-based markets and strong opex controls. The analyst expects October quarterly earnings of 90c and $942M, in line with consensus, to prove to be conservative and sees meaningful accretion from the Linear Technology (LLTC) deal adding 84c to 2018 earnings and believes cost savings of $150M will prove to be too low.
DSW DSW

11/02/16
WEDB
11/02/16
INITIATION
Target $22
WEDB
Neutral
DSW initiated with a Neutral at Wedbush
Wedbush analyst Christopher Svezia initiated DWS with a Neutral and a $22 price target.
11/04/16
STPT
11/04/16
INITIATION
Target $28
STPT
Buy
DSW initiated with a Buy at Standpoint Research
Standpoint initiated DSW with a Buy and a $28 price target.
11/01/16
WEDB
11/01/16
INITIATION
Target $22
WEDB
Neutral
DSW initiated with a Neutral at Wedbush
Target $22.
11/02/16
11/02/16
INITIATION

On The Fly: Top analyst initiations
Catch up on today's top analyst initiations with this list compiled by The Fly: 1. Alcoa (AA) initiated with a Neutral at Goldman and an Underperform at BofA/Merrill. 2. Everspin Technologies (MRAM) initiated with a Buy at Craig-Hallum, a Buy at Stifel, a Buy at Canaccord, and a Strong Buy at Needham. 3. Amazon.com (AMZN), Dick's Sporting (DKS), Foot Locker (FL), Finish Line (FINL), and Columbia Sportswear (COLM) were initiated with an Outperform at Wedbush while the firm initiated Nike (NKE) and DSW (DSW) with a Neutral. 4. FedEx (FDX) initiated with a Buy at Deutsche Bank while the firm initiated UPS (UPS) with a Hold. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
THC Tenet

11/10/16
RAJA
11/10/16
DOWNGRADE
RAJA
Market Perform
Tenet downgraded to Market Perform from Outperform at Raymond James
11/22/16
MZHO
11/22/16
DOWNGRADE
MZHO
Underperform
Tenet downgraded to Underperform from Neutral at Mizuho
Mizuho downgraded Tenet to Underperform citing premium valuation and lack of visibility on what will happen to ACA, Medicaid, and Medicare.
11/10/16
11/10/16
DOWNGRADE

Market Perform
Tenet downgraded to Market Perform at Raymond James
As previously reported, Raymond James downgraded Tenet to Market Perform from Outperform. The firm's analyst said Tenet's valuation appears to be pricing in a "repeal" of ACA while forgetting the "replace" aspect and notes there is not sufficient detail on what Trump's policy proposals on healthcare will look like yet.
11/09/16
BOFA
11/09/16
DOWNGRADE
Target $25
BOFA
Tenet downgraded to Neutral following Trump victory at BofA/Merrill
As previously reported, BofA/Merrill Tenet to Neutral from Buy and lowered its price target to $25 from $32. Analyst Kevin Fischbeck said the Trump victory and Republican sweep of Congress is a negative for the entire Healthcare Facilities sector as Republicans want to repeal the Affordable Care Act and cut spending. The analyst said the trend is towards less coverage, which will impact volumes and increase bad debt in general. For Tenet in particular, Fischbeck expects Acute care growth to slow and return back to the long-term average.
MOV Movado

02/19/16
SIDC
02/19/16
INITIATION
Target $34
SIDC
Buy
Movado initiated with a Buy at Sidoti
Target $34.

TODAY'S FREE FLY STORIES

11:06
12/08/16
12/08
11:06
12/08/16
11:06
General news
The Fly announces rebranding, launch of new website »

The Fly, formerly known…

BA

Boeing

$155.03

0.89 (0.58%)

11:03
12/08/16
12/08
11:03
12/08/16
11:03
Hot Stocks
Boeing reports two new 787 orders in weekly update »

Boeing on its website…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

A

Agilent

$45.15

0.1639 (0.36%)

11:03
12/08/16
12/08
11:03
12/08/16
11:03
Hot Stocks
Agilent, Transcriptic collaborate to automate discovery biology »

Agilent Technologies and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APOL

Apollo Education

$9.52

0.01 (0.11%)

, DV

DeVry

$31.48

0.325 (1.04%)

11:01
12/08/16
12/08
11:01
12/08/16
11:01
Hot Stocks
Apollo Education slides after DoE response to preacquisition review application »

Shares of for-profit…

APOL

Apollo Education

$9.52

0.01 (0.11%)

DV

DeVry

$31.48

0.325 (1.04%)

ESI

ITT Educational

EDMC

Education Management

$0.01

0.001 (11.11%)

CECO

Career Education

$10.22

-0.03 (-0.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

  • 09

    Dec

ASUR

Asure Software

$8.38

0.37 (4.62%)

11:01
12/08/16
12/08
11:01
12/08/16
11:01
Conference/Events
Asure Software management to meet with Lake Street »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 06

    Dec

BA

Boeing

$154.95

0.81 (0.53%)

11:01
12/08/16
12/08
11:01
12/08/16
11:01
Hot Stocks
Boeing begins final assembly on first 787-10 Dreamliner »

Boeing teammates in North…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HNR

Harvest Natural

$5.46

-0.19 (-3.36%)

11:00
12/08/16
12/08
11:00
12/08/16
11:00
Periodicals
Harvest Natural mentioned cautiously by TheStreetSweeper »

TheStreetSweeper's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DISH

DISH

$58.64

0.13 (0.22%)

11:00
12/08/16
12/08
11:00
12/08/16
11:00
Technical Analysis
DISH spikes off session lows »

The shares were last at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANET

Arista Networks

$96.87

-1 (-1.02%)

11:00
12/08/16
12/08
11:00
12/08/16
11:00
Conference/Events
Arista Networks management to meet with Pacific Crest »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 12

    Dec

NFLX

Netflix

$125.39

0.82 (0.66%)

11:00
12/08/16
12/08
11:00
12/08/16
11:00
Options
Netflix short-term calls are active »

Netflix short-term calls…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:00
12/08/16
12/08
11:00
12/08/16
11:00
General news
Treasury futures action: some block buying »

Treasury futures action:…

AMAT

Applied Materials

$32.51

0.9 (2.85%)

10:58
12/08/16
12/08
10:58
12/08/16
10:58
Conference/Events
Applied Materials management to meet with Stifel »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

DISH

DISH

$58.64

0.13 (0.22%)

10:57
12/08/16
12/08
10:57
12/08/16
10:57
Rumors
Rumor moving shares of DISH »

Rumor: DISH active amid…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:55
12/08/16
12/08
10:55
12/08/16
10:55
Conference/Events
Stifel electrical equipment analysts to hold a luncheon meeting »

Electrical, Networking…

IWM

iShares Trust Russell 2000 Index Fund

$136.53

0.625 (0.46%)

, RUT

Russell 2000 Index

10:53
12/08/16
12/08
10:53
12/08/16
10:53
Technical Analysis
Russell 2000 Index hits new life high »

The index was last at…

IWM

iShares Trust Russell 2000 Index Fund

$136.53

0.625 (0.46%)

RUT

Russell 2000 Index

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HYG

iShares iBoxx $ High Yield Corporate Bond

$86.22

-0.24 (-0.28%)

10:50
12/08/16
12/08
10:50
12/08/16
10:50
Options
Notable put activity in the High Yield Bond Fund »

Notable put activity in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NOC

Northrop Grumman

$241.93

-5.21 (-2.11%)

10:45
12/08/16
12/08
10:45
12/08/16
10:45
Technical Analysis
Northrop Grumman trades lower, levels to watch »

Shares are down over 2.3%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKS

AK Steel

$11.03

0.24 (2.22%)

10:45
12/08/16
12/08
10:45
12/08/16
10:45
Options
AK Steel call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:45
12/08/16
12/08
10:45
12/08/16
10:45
General news
Breaking General news story  »

6-Month Bill Announcement…

10:45
12/08/16
12/08
10:45
12/08/16
10:45
General news
Breaking General news story  »

3-Month Bill Announcement…

EXA

Exa Corp.

$14.44

-0.36 (-2.43%)

10:44
12/08/16
12/08
10:44
12/08/16
10:44
Conference/Events
Exa Corp. to host analyst and investor day »

Analyst and Investor Day…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RMD

ResMed

$60.65

0.31 (0.51%)

10:40
12/08/16
12/08
10:40
12/08/16
10:40
Conference/Events
ResMed management to meet with William Blair »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 12

    Dec

ESPR

Esperion

$11.50

-0.18 (-1.54%)

10:38
12/08/16
12/08
10:38
12/08/16
10:38
Conference/Events
Esperion management to meet with JMP Securities »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

LPLA

LPL Financial

$37.94

0.97 (2.62%)

10:37
12/08/16
12/08
10:37
12/08/16
10:37
Periodicals
Breaking Periodicals news story on LPL Financial »

LPL Financial said to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EROS

Eros International

$14.18

0.375 (2.72%)

10:36
12/08/16
12/08
10:36
12/08/16
10:36
Conference/Events
Eros International management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.